Fundz

Serán Bioscience secures a growth investment from Biospring Partners, alongside Vivo Capital and Bain Capital, to accelerate commercial expansion and meet customer demand.

PRIVATESep 29, 2026

Round Type

Venture

BendManufacturingBiotechnology

Investors

Vivo CapitalBain Capital Life SciencesBiospring Partners

Description

Serán Bioscience, a contract development and manufacturing organization, has announced a growth investment led by Biospring Partners. The financing also saw participation from existing investors like Vivo Capital and Bain Capital Life Sciences. This new capital will help the company strengthen its spray dry capabilities. The funds aim to support Serán's commercial expansion to meet increasing customer demand.

Quick answer

Serán Bioscience raised an undisclosed amount in a funding round, dated September 29, 2026. Investors: Vivo Capital, Bain Capital Life Sciences and Biospring Partners. Serán Bioscience is based in Bend, Oregon, United States.

How much did Serán Bioscience raise?
Serán Bioscience raised an undisclosed amount in a funding round on September 29, 2026.
Who invested in Serán Bioscience?
Vivo Capital, Bain Capital Life Sciences and Biospring Partners are named as investors in this round.
What does Serán Bioscience do?
Serán Bioscience is a leading contract development and manufacturing organization (CDMO) that specializes in development, analytical, and manufacturing solutions for pharmaceutical and biotechnology companies.
Where is Serán Bioscience based and how big is it?
Serán Bioscience is based in Bend, Oregon, United States. Fundz records about 201 employees.
Who are the decision-makers at Serán Bioscience?
Fundz holds 2 contacts at Serán Bioscience, including the Sr. VP Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Serán Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • XTPL raised $6.5M on November 13, 2026.
  • Biomatter raised $18M (Series A) on November 12, 2026.
  • Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
  • FluoRok raised $30M (Series A) on November 5, 2026.
  • altM raised $10M (Series A) on November 5, 2026.
  • Alt Material Innovations Private Limited raised $318K (Series A) on November 4, 2026.

Who to call at Serán Bioscience, and when

A new round usually means Serán Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Serán Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Serán Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Serán Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Serán Bioscience

Location

Bend, Oregon, United States

About

Serán Bioscience is a leading contract development and manufacturing organization (CDMO) that specializes in development, analytical, and manufacturing solutions for pharmaceutical and biotechnology companies. The company focuses on enhancing its capabilities to meet the needs of its clients. It aims to accelerate its commercial expansion to respond to growing customer demand.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Serán Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJeffrey E., Sr. VP Operations hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Serán Bioscience's next move

See what Strategic adds

Serán Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.